SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-002647
Filing Date
2015-03-24
Accepted
2015-03-24 16:11:58
Documents
5
Period of Report
2015-04-24
Effectiveness Date
2015-03-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2223707zdef14a.htm DEF 14A 802420
2 G539869.JPG g539869.jpg GRAPHIC 8175
3 G500106.JPG g500106.jpg GRAPHIC 6247
4 G15192BII001.GIF g15192bii001.gif GRAPHIC 62788
5 G15192BII002.GIF g15192bii002.gif GRAPHIC 39396
  Complete submission text file 0001047469-15-002647.txt   964783
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 15721856
SIC: 2834 Pharmaceutical Preparations